Thompson Davis & Co’s Sanofi SNY Stock Holding History

Thompson Davis & Co’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-881	Closed	-$44K	–	1033
2017 Q3	$44K	Sell	881 -90	-9%	-$4.36K	0.08%	260
2017 Q2	$47K	Hold	971	–	–	0.08%	238
2017 Q1	$44K	Hold	971	–	–	0.06%	269
2016 Q4	$39K	Buy	971 +50	+5%	+$1.97K	0.06%	287
2016 Q3	$35K	Sell	921 -105	-10%	-$4.21K	0.06%	306
2016 Q2	$43K	Buy	1,026 +250	+32%	+$10.3K	0.07%	277
2016 Q1	$31K	Buy	776 +225	+41%	+$9.04K	0.05%	327
2015 Q4	$24K	Buy	551 +100	+22%	+$4.6K	0.03%	423
2015 Q3	$21K	Sell	451 -87	-16%	-$4.43K	0.03%	455
2015 Q2	$27K	Sell	538 -28	-5%	-$1.42K	0.03%	460
2015 Q1	$28K	Sell	566 -52	-8%	-$2.49K	0.03%	444
2014 Q4	$28K	Buy	618 +261	+73%	+$12.7K	0.03%	429
2014 Q3	$20K	Buy	+357	New	+$19.2K	0.03%	464

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Thompson Davis & Co's SNY Position: Q4 2017 in Review

Thompson Davis & Co sold out of Sanofi (SNY) in Q4 2017, closing a stake of 881 shares — an estimated $44K sold.

Thompson Davis & Co first reported a position in SNY in Q3 2014 and held it in 13 quarters. The position peaked at $47K in Q2 2017. 504 funds tracked by Wall St. Rank hold SNY as of Q4 2017.

Thompson Davis & Co reported no remaining Sanofi position as of Q4 2017 after selling out during the quarter.
Thompson Davis & Co sold 881 Sanofi shares in Q4 2017, an estimated $44K.
Thompson Davis & Co first reported a position in Sanofi in Q3 2014 and held it in 13 quarters.
Thompson Davis & Co's Sanofi position peaked at $47K in Q2 2017.
504 funds tracked by Wall St. Rank held Sanofi as of Q4 2017.

Based on Thompson Davis & Co's 13F filing for Q4 2017, filed 5 Feb 2018.